Photos

The exterior of Gilead Sciences Inc. in Foster City, California is pictured in this undated handout photo provided by Gilead Sciences Inc. Gilead Sciences Inc on February 3, 2015 said it is offering steeper-than-expected discounts on its hepatitis C drugs to health insurers and other group payers who had complained about the price, and the drugmaker's shares slid more than 5 percent. Gilead executives disclosed the discounts on a conference call after the company said strong sales of the drugs, Harvoni and Sovaldi, helped boost net profit more than four-fold in the latest quarter, beating Wall Street forecasts. REUTERS/Gilead Sciences Inc./Handout via Reuters (UNITED STATES - Tags: DRUGS SOCIETY HEALTH BUSINESS)
\ATTENTION EDITORS - NO SALES. NO ARCHIVES. FOR EDITORIAL USE ONLY. NOT FOR SALE FOR MARKETING OR ADVERTISING CAMPAIGNS. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. IT IS DISTRIBUTED, EXACTLY AS RECEIVED BY REUTERS, AS A SERVICE TO CLIENTS